AAAAAA
Results:
1-18
|
Results: 18
Authors:
MULLER W
MESKE V
BERLIN K
SCHARNAGL H
MARZ W
OHM TG
Citation: W. Muller et al., APOLIPOPROTEIN-E ISOFORMS INCREASE INTRACELLULAR CA2-AGATOXIN IVA-SENSITIVE CA2+-CHANNEL( DIFFERENTIALLY THROUGH AN OMEGA), Brain pathology, 8(4), 1998, pp. 641-653
Authors:
MARZ W
HOFFMANN MM
SCHARNAGL H
FISHER E
CHEN MC
NAUCK M
FEUSSNER G
WIELAND H
Citation: W. Marz et al., APOLIPOPROTEIN E2 (ARG(136)-]CYS) MUTATION IN THE RECEPTOR-BINDING DOMAIN OF APOE IS NOT ASSOCIATED WITH DOMINANT TYPE-III HYPERLIPOPROTEINEMIA, Journal of lipid research, 39(3), 1998, pp. 658-669
Authors:
GIERENS H
NAUCK MS
ROTH M
SCHINKER R
SCHARNAGL H
WIELAND H
MAERZ W
Citation: H. Gierens et al., INTERLEUKIN-6 STIMULATES THE EXPRESSION OF LDL RECEPTORS VIA THE CIS-ACTING STEROL-RESPONSIVE ELEMENT (SRE), Circulation, 98(17), 1998, pp. 544-544
Authors:
SCHAEFER JR
SCHARNAGL H
BAUMSTARK MW
SCHWEER H
ZECH LA
SEYBERTH H
WINKLER K
STEINMETZ A
MARZ W
Citation: Jr. Schaefer et al., HOMOZYGOUS FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100 - ENHANCED REMOVALOF APOLIPOPROTEIN E-CONTAINING VLDLS AND DECREASED PRODUCTION OF LDLS, Arteriosclerosis, thrombosis, and vascular biology, 17(2), 1997, pp. 348-353
Authors:
WINKLER K
SCHARNAGL H
HOSCHUTZKY B
HOFFMANN MM
FRIEDRICH I
WIELAND H
MARZ W
Citation: K. Winkler et al., APOLIPOPROTEIN-E AND BETA-A4 AMYLOID ARE IMMUNOLOGICALLY AND FUNCTIONALLY RELATED, Atherosclerosis, 134(1-2), 1997, pp. 21-21
Authors:
NAUCK M
SCHARNAGL H
KOSTER W
NISSEN H
MARZ W
WIELAND H
Citation: M. Nauck et al., MUTATIONS IN THE GENES ENCODING THE LOW-DENSITY-LIPOPROTEIN RECEPTOR AND APOLIPOPROTEIN-B IN SOUTHWEST GERMANY, Atherosclerosis, 134(1-2), 1997, pp. 70-71
Authors:
MARZ W
SCHARNAGL H
ABLETSHAUSER C
WIELAND H
BAUMSTARK M
Citation: W. Marz et al., EFFECT OF FLUVASTATIN ON SMALL DENSE LOW-DENSITY LIPOPROTEINS IN POSTMENOPAUSAL WOMEN WITH AN ATHEROGENIC LIPOPROTEIN PHENOTYPE, Atherosclerosis, 134(1-2), 1997, pp. 129-129
Authors:
WINKLER K
SCHAFER J
KLIMA B
SCHARNAGL H
NUBER C
GRATHWOHL D
KOSTER W
WIELAND H
MARZ W
Citation: K. Winkler et al., INFLUENCE OF LIFIBROL THERAPY ON APO-B METABOLISM IN MIRED HYPERLIPIDEMIA AND HYPERCHOLESTEROLEMIC PATIENTS, Atherosclerosis, 134(1-2), 1997, pp. 135-135
Authors:
SCHARNAGL H
FEUSSNER G
ACAR J
WIELAND H
MARZ W
Citation: H. Scharnagl et al., APOLIPOPROTEIN-E DEFICIENT REMNANT LIPOPROTEINS AND RECOMBINANT APOLIPOPROTEIN-E - A NEW MODEL TO CHARACTERIZE THE INTERACTION OF APOLIPOPROTEIN-E WITH LIPOPROTEIN RECEPTORS AND PROTEOGLYCANS, Atherosclerosis, 134(1-2), 1997, pp. 361-361
Authors:
MARZ W
SCHARNAGL H
WINKLER K
GIERENS H
NAUCK M
HOFFMANN M
KLIMA B
SCHLIACK M
LOSER R
LANG G
GROSS W
WIELAND H
Citation: W. Marz et al., LIFIBROL (K12.148) - FIRST MEMBER OF A NEW CLASS OF HYPOLIPIDEMIC DRUGS, Atherosclerosis, 130, 1997, pp. 18-18
Authors:
FEUSSNER G
SCHARNAGL H
SCHERBAUM C
ACAR J
DOBMEYER J
LOHRMANN J
WIELAND H
MARZ W
Citation: G. Feussner et al., APOLIPOPROTEIN E5 (GLU(212)-]LYS) - INCREASED BINDING TO CELL-SURFACEPROTEOGLYCANS BUT DECREASED UPTAKE AND LYSOSOMAL DEGRADATION IN CULTURED FIBROBLASTS, Journal of lipid research, 37(8), 1996, pp. 1632-1645
Authors:
OHM TG
KIRCA M
BOHL J
SCHARNAGL H
GROSS W
MARZ W
Citation: Tg. Ohm et al., APOLIPOPROTEIN-E POLYMORPHISM INFLUENCES NOT ONLY CEREBRAL SENILE PLAQUE LOAD BUT ALSO ALZHEIMER-TYPE NEUROFIBRILLARY TANGLE FORMATION, Neuroscience, 66(3), 1995, pp. 583-587
Authors:
SCHARNAGL H
MARZ W
SCHLIACK M
LOSER R
GROSS W
Citation: H. Scharnagl et al., A NOVEL ASSAY FOR CYTOSOLIC 3-HYDROXY-3-METHYGLUTARYL-COENZYME-A SYNTHASE ACTIVITY USING REVERSED-PHASE ION-PAIR CHROMATOGRAPHY - DEMONSTRATION THAT LIFIBROL (K12.148) MODULATES THE ENZYME-ACTIVITY, Journal of lipid research, 36(3), 1995, pp. 622-627
Authors:
DUROVIC S
MARZ W
FRANK S
SCHARNAGL H
BAUMSTARK MW
ZECHNER R
KOSTNER GM
Citation: S. Durovic et al., DECREASED BINDING OF APOLIPOPROTEIN (A) TO FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100 (ARG(3500)-]GLN) - A STUDY OF THE ASSEMBLY OF RECOMBINANT APOLIPOPROTEIN (A) WITH MUTANT LOW-DENSITY LIPOPROTEINS, The Journal of biological chemistry, 269(48), 1994, pp. 30320-30325
Authors:
MARZ W
SCHARNAGL H
BECKMANN A
SIEKMEIER R
MONDORF U
GROSS E
GROSS W
SCHARRER I
HUTTINGER M
Citation: W. Marz et al., INTERACTION OF LIPOPROTEIN (A) SIZE ISOFORMS WITH ENDOTHELIAL-CELLS, HUMAN SKIN FIBROBLASTS, AND RAT MESANGIAL CELLS - EVIDENCE THAT LP(A) IS TAKEN UP BY LDL-RECEPTORS AND LDL-RECEPTOR INDEPENDENT PATHWAYS, Thrombosis and haemostasis, 69(6), 1993, pp. 769-769
Authors:
MARZ W
BAUMSTARK MW
SCHARNAGL H
RUZICKA V
BUXBAUM S
HERWIG J
POHL T
RUSS A
SCHAAF L
BERG A
BOHLES HJ
USADEL KH
GROSS W
Citation: W. Marz et al., ACCUMULATION OF SMALL DENSE LOW-DENSITY LIPOPROTEINS (LDL) IN A HOMOZYGOUS PATIENT WITH FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100 RESULTS FROM HETEROGENOUS INTERACTION OF LDL SUBFRACTIONS WITH THE LDL RECEPTOR, The Journal of clinical investigation, 92(6), 1993, pp. 2922-2933
Authors:
MARZ W
BECKMANN A
SCHARNAGL H
SIEKMEIER R
MONDORF U
HELD I
SCHNEIDER W
PREISSNER KT
CURTISS LK
GROSS W
HUTTINGER M
Citation: W. Marz et al., HETEROGENEOUS LIPOPROTEIN (A) SIZE ISOFORMS DIFFER BY THEIR INTERACTION WITH THE LOW-DENSITY-LIPOPROTEIN RECEPTOR AND THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN ALPHA(2)-MACROGLOBULIN RECEPTOR, FEBS letters, 325(3), 1993, pp. 271-275
Authors:
MARZ W
SIEKMEIER R
SCHARNAGL H
SEIFFERT UB
GROSS W
Citation: W. Marz et al., FAST LIPOPROTEIN CHROMATOGRAPHY - NEW METHOD OF ANALYSIS FOR PLASMA-LIPOPROTEINS, Clinical chemistry, 39(11), 1993, pp. 2276-2281
Risultati:
1-18
|